Study the pharmacodynamics of neuromuscular blockade and selective relaxant-binding agent using the body composition measuring device in obese patients.

Study the pharmacodynamics of neuromuscular blockade and selective relaxant-binding agent using the body composition measuring device in obese patients. - The pharmacodynamics of rocuronium and sugammadex using the body composition measuring device in obese patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018194

Enrollment

100

Registered

2015-07-05

Start date

2015-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: BMI25 kg/m2 or more in the obesity, American Society of Anesthesiologists Physical States in class I-III, the men and women of more than 20-year-old. Patients undergoing surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: American Society of Anesthesiologists Physical States in class over IV. Under 20-year-old. Pregnant woman. Patients who do not obtain their consent.

Design outcomes

Primary

Measure	Time frame
Train of four ratio.	—

Countries

Japan

Contacts

Public ContactNami Kakuta

Institute of Biomedical Sciences Tokushima University Graduate School Department of Anesthesiology

kakuta.nami@tokushima-u.ac.jp088-633-7181

Outcome results